ESR2 and non-small cell lung carcinoma: It was because estrogen increased NSCLC metastasis through the ERβ by upregulating TLR4 and activating the myeloid differentiation factor 88 (myd88)/nuclear factor kappa B (NF-κB)/MMP-2 signaling axis in vitro [123].